References
- Goltzman, D. Discoveries, drugs and skeletal disorders. Nat Rev Drug Discov 10: 784-796, 2002.
- Ballabriga, A. Morphological and physiological changes during growth: an update. Eur. J. Clin. Nutr. 54 Suppl 1: S1-6, 2000.
- Seeman, E. Is a change in bone mineral density a sensitive and specific surrogate of anti-fracture efficacy. Bone. 41: 308-317, 2007. https://doi.org/10.1016/j.bone.2007.06.010
- Becker, D.J., Kilgore, M.L., Morrisey, M.A. The societal burden of osteoporosis. Curr. Rheumatol. Rep. 12: 186-191, 2010. https://doi.org/10.1007/s11926-010-0097-y
- Rodan, G.A., Martin, T.J. Therapeutic approaches to bone diseases. Science 289: 1508-1514, 2000. https://doi.org/10.1126/science.289.5484.1508
- Ilich, J.Z., Kerstetter, J.E. Nutrition in bone health revisited: a story beyond calcium. J Am Coll Nutr 19: 715-737, 2000. https://doi.org/10.1080/07315724.2000.10718070
- Teitelbaum, S.L. Bone resorption by osteoclasts. Science, 289: 1504-1508, 2000. https://doi.org/10.1126/science.289.5484.1504
- Takayanagi, H. Mechanistic insight into osteoclast differentiation in psteoimmunology. J. Mol. Med. 83: 170-179, 2005. https://doi.org/10.1007/s00109-004-0612-6
- Rao, A., Luo, C., Hogan, P.G. Transcription factors of the NFAT family: regulation and function. Annu. Rev. Immunol., 15: 707-747, 1997. https://doi.org/10.1146/annurev.immunol.15.1.707
- Takayanagi, H. Osteoimmunology: shared mechanisms and cross talk between the immune and bone systems. Nat. Rev. Immunol., 7: 292-304, 2007. https://doi.org/10.1038/nri2062
- Abrahamsen, B. Bisphosphonate adverse effects, lessons from large databases. Curr Opin Rheumatol 22(4):404-409, 2010. https://doi.org/10.1097/BOR.0b013e32833ad677
- 소학관. 상해과학기술출판사, 중약대사전. 상해, 4: 2312, 1975.
- Zhu, Y.P. Harwood Academic Publisher, Amsterdam. Chinese Materia Medica. 311, 1998.
- Korczowska, I., Olewicz-Gawlik, A. Does low-dose and short-term glucocorticoids treatment increase the risk of osteoporosis in rheumatoid arthritis female patients Clin Rheumatol. May; 27(5):565-572, 2008. https://doi.org/10.1007/s10067-007-0747-2
- 권미선, 정신교, 최종옥, 송경식, 이인선, 최종욱. Antimicrobial and Antitumor Activity of Triterpenoids Fraction from Poria cocos Wolf. Journal of Food Science and Nutrition 28(5):1029-1033, 1999.
- Dougall, W.C., Glaccum, M., Charrier, K., Rohrbach, K., Brasel, K., De Smedt, T., Daro, E., Smith, J., Tometsko, M.E., Maliszewski, C.R., Armstrong, A., Shen, V., Bain, S., Cosman, D., Anderson, D., Morrissey, P.J., Peschon, J.J., Schuh, J. RANK is essential for osteoclast and lymph node development. Genes & Development 13: 2412-2424, 1999. https://doi.org/10.1101/gad.13.18.2412
- H. Takayanagi, S. Kim, T. Koga, H. Nishina, M. Isshiki, H. Yoshida, A. Saiura, M. Isobe, T. Yokochi, J. Inoue, E.F. Wagner, T.W. Mak, T. Kodama, T. Taniguchi Developmental Cell, 3: 889, 2002. https://doi.org/10.1016/S1534-5807(02)00369-6
- M. Matsumoto, M. Kogawa, S. Wada, H. Takayanagi, M. Tsujimoto, S. Katayama, K. Hisatake, Y. Nogi, The Journal of Biological Chemistry 279: 45969, 2004. https://doi.org/10.1074/jbc.M408795200
-
Galibert, L., Tometsko, M.E., Anderson, D.M., Cosman, D., Dougall, W.C. The involvement of multiple tumor neocrosis factor receptor (TNFR)-associated factors in the signaling mechanism of receptor activator of
$NF-{\kappa}B$ , a member of the TNFR superfamily. J Biol Chem 273: 34120-34127, 1998. https://doi.org/10.1074/jbc.273.51.34120